Genetics (Bacteria)

Milestone Achieved and Agreements Announced for Bacterial Genomes

Published in Gene Therapy Weekly, July 21st, 1997

Human Genome Sciences, Inc. (HGS), Rockville, Maryland, announced that it has sequenced the Streptococcus pneumoniae genome, a major bacterial pathogen responsible for severe respiratory and other infections.

In March 1996, HGS licensed F. Hoffman-La Roche, Basel, Switzerland, and Hoffmann-La Roche Inc. (Roche), Nutley, New Jersey, the right to use the S. pneumoniae sequence information to identify potential new anti-infectives and antibiotics in return for an upfront payment, a milestone related to sequencing, and royalties on the sale of certain products.

S. pneumoniae is the most common cause of bacterial pneumonia. Although...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-07-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry